Antimicrobial‐ResistantNocardiaIsolates, United States, 1995–2004 | Zendy

Kristin Broome Uhde | Zendy; Sonal Pathak | Zendy; Isaac McCullum | Zendy; Deanna JannatKhah | Zendy; Sean V. Shadomy | Zendy; Clare A. Dykewicz | Zendy; Thomas A. Clark | Zendy; Theresa L. Smith | Zendy; June M. Brown | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial‐ResistantNocardiaIsolates, United States, 1995–2004

Author(s) -

Kristin Broome Uhde,

Sonal Pathak,

Isaac McCullum,

Deanna JannatKhah,

Sean V. Shadomy,

Clare A. Dykewicz,

Thomas A. Clark,

Theresa L. Smith,

June M. Brown

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/657399

Subject(s) - sulfamethoxazole , trimethoprim , nocardia , microbiology and biotechnology , antimicrobial , medicine , epidemiology , nocardia infections , disease control , antibiotics , virology , biology , nocardiosis , bacteria , genetics

We conducted a 10-year retrospective evaluation of the epidemiology and identification of Nocardia isolates submitted to the Centers for Disease Control and Prevention for antimicrobial susceptibility testing. The species most commonly identified were N. nova (28%), N. brasiliensis (14%), and N. farcinica (14%). Of 765 isolates submitted, 61% were resistant to sulfamethoxazole and 42% were resistant to trimethoprim-sulfamethoxazole.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research